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mg./kg. During the last month it was 2 to 6 mg./kg. per week. 
It should be noted that the greatest quantity of horse protein 
given per week per kilogram was one-third to one-sixtieth of that 
d iitres against sheep red blobd cells were monitored in alIiatients I, as an indicator of the res~onse to anv Forssman-like antigens I 
-- 
constructed by means of double dilution of pooled sera from two PREDNISONE &pfi &++, $, ", 
oatients with known hvpersensitivitv to horse orotein: when (mom /day) 20 
tion band;of test sera could thus be accuratelv measuredand con- 
verted to a unit basis bv reading off this standard curve. This TIME IN DAYS 
I: u provided an extremely iensitive way of following changes in RC, I .  COUrseOfap~tielltwhorecei . .- -. . . . . . titre in the ALG-treated patients, but as these the The hotl~ograft was provided by a brurucr. I ~ ~ c t r e  nas never ueen a rejccclon. I   in known precipitin content in the standard serum. Studies are sone was started after 40 days because o f  the increases in haemaggluti~lin and ,.--.,..... under way to obtain quantitative precipitin titres against k~lown titres. Note the subsequent decline in these measures despite continuatio~l o f  the globulill amounts of specific classes of horse immuno~lobulins so that . .  . i~~jections. 
u d 
has made or started in small doses from the day of operation; with TO fflce p. 6 , 
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theselectivity which was attemptedin group 3 was a distinguishing 
feature, particularly since a few patients were denied transplanta- 
tion during this period on the grounds that a reasonable match 
could not be found. In contrast, it has been pointed out that the 
differential and total counts in the various groups. Each of the 
first ten patients treated with ALG contributed to this analysis 
since there were no deaths. In contrast, nine, two, and three, 
Histopathological studies. The first eight patients in the ALG In addition, autopsy tissue becaine available from the 14th 
series had biopsies of their homografts taken from 108 to 145 days patient in the series who died 42 days after homotransplantation 
after homotransplantation. The last injection of horse protein had of a fraternal kidney, and eight days after placement of an addi- 
been from I to 30  days previously in seven ofthe cases, and 56 days tional cadaveric homograft. 
before in the eighth. At the time of biopsy, all of these recipients 
had excellent renal function. The mean BUN for the group was Late cares 
26.7+ 5 '5 (s.D.) n ~ g . / ~ o o  ml., plasma creatinine 0.92 + 0.15 (s.D.) Four patients had received homografts from 5 to 11 iilonths 
ing./~oo ml., creatinine clearance 97.4+ 21.2 (s.D.) ml./min., previously, two from cadavers and two from their mothers. In 
inulin clearance 60.9 + 12 6 (s.D.) ml./min., and para-aminohip- each case, deterioration of renal f~inction occurred when the 
puric acid (PAH) clearance 348 '9 + 65 - 5 (s.D.) ml.jmin. The I prednisone dose was reduced below 0.5 to I .7 mg./kg. per day. 
filtratioil fraction was 17.9 + 3 3 (s.D.) per cent. Urine protein In addition, three of the four patients had developed serious 
concentration was 5.4+ 3 -6  (s.D.) mg./~oo n~ l .  Dr. David A. infectious complications. 
Ogden, who performed these clearances, also studied all eight In all four cases, a four-month course of ALG therapy was 
doilors at the same time. The pooled function in the recipients started, similar to that described earlier for newly operated cases. 
was not significantly different from that in their donors. After a few days, a drastic progressive attenuation ofthe prednisone 
Large wedge biopsies were removed under local anaesthesia, dose was begun which reached a low of 0.23 to 0.3 ing./kg. per 
and divided into four portions. One part was fored in 10 per cent day in three patients; azathioprine was continued. All inlmuno- 
buffered formalin, embedded in paraffin wax, serially sectioned suppressive therapy was eventually stopped for the fourth patient. 
and stained with haematoxylin and eosin, periodic-acid Schiff 
and Weigert's elastic-tissue stain. Another part of the biopsy was RESULTS 
immediately cut into small cubes, fwed in Palade's buffered 
osini~iin tetroxide and embedded in Epon 812. Sections 0.5 p in Newly operated cnses 
matrix. Several tufts were hypercellular because of mesangial ln control groups 1-3 (Fig. 3). The ALGtreated patients had the 
and endothelid cell hyperplasia. The tubules were lined by lowest early mortality. Furthermore, there have been no delayed 
flattened atrophic epithelium and there was general interstitial deaths in the first 12 consecutive cases after an observation period 
oedema and fibrosis. Several interlobular and arcuate arteries of three to seven months. The immediate impression was that for 
were slightly narrowed by fibrous intimal thickening. There were GROUP I - 23 PATIENTS 
a few inflltrating mononuclear cells in the interstitiurn and in the GROUP P - Iz PATIENTS 
GROUP 3 - 22 PATIENTS 
GROUP 4 (ALGI-  10 PATIENTS 
GRWP 1 + 32 PATIENTS 
GROUP I1 * 14 PATIENTS 
GROUP 111 + 25 PATIENTS 
ALG + 2 0  PATIENTS 
TIME IN MONTHS FIG. 4. Average daily doses of azathioprine and prednisone for the 
FIG. 3. Mortality in patients treated with adjuvant ALG compared to first 15 postoperative weeks in three preceding series of consanguineous 
that in three preceding series of consanguineous transplantations homotransplantations done in Denver, compared to the doses used 
carried out in Denver. The numbers in the ALG series refer to the for the first ten consecutive patients treated with adjuvant ALG. 
patients at risk at the indicated times. Since inclusion in the study was contingent upon survival for this period, nine, two and three other patients from the retrospective con- 
trol series were eliminated by their early death; such a correction was 
unnecessary in the ALG cases. Note that the ALG-treated patients 
received reduced quantities of the "standard" ilnmutlosuppressive 
agents. 
reasons requiring further clarification the loss rate in this group 
was cut during both the acute and chronic phases ofconvalescence. 
Immunosuppression and function. During the time when control 
groups 1-3 were compiled, there was a progressive tendency to 
use smaller doses of azathioprine (Fig. 4) in an effort to prevent the 
bone marrow depression and sepsis which were responsible for 
most ofthe early deaths. This trendcontinuedinto the first 105-day 
period of the ALG series, during which the azathioprine doses 
important to re-emphasize that inclusion in the statistical evalua- were smaller than in any preceding group (Fig. 4). The linear 
tion was contingent upon survival for the study period, a require- downward change was statistically significant (PC 0.005). 
In contrast, the average steroid doses during the first 105 days ment which was met by each of the first ten ALG-treated patients. 
of recovery were almost identical in the first two control groups 
BLOOD UREA 
--- 3 
GROUP 1 - 2 3  PATIENTS (23132)  
GROUP2 ' I I  PATIENTS (11/141 
GROUP 3 - 22 PATIENTS ( 2 2 / 2 5 )  
GRWP 4 - B PATIENTS ( B / B )  
FIG. 5 .  Average weekly renal function for the first IS  post-transplant 
weeks in the same retrospective control and test cases shown in Fig. 4. 
The BUN and creatinine values were not significantly different in any 
of the series, but the creatinine clearances in group 3 were depressed 
to a statistically significant degree (0.025 > P>o.or). See text for 
details. 
TIME IN WEEKS 
FIG. 6. Relation of average prednisone doses to creatinine clearances (Ccr) durillg tlie 
' first 22 weeks for the first eight ALG-treated patients, compared to comparable data in 
the three retrospective control series. Note that the patients in the ALG group received 
the smallest quantities of steroids, and that they ultimately had the highest average 
clearances. 
In contrast, 14 unsuccessfully treated control patients who 
generally had poorer renal function and higher drug doses than 
the other members of their respective series were excluded. The 
favourable showing of the ALG group was in spite of this bias. 
Further analysis of the weekly renal function of the f ~ s t  eight 
ALGtreated patients during the first 5& postoperative nlonths 
spective control group z (Fig. 5). In interpreting this finding, it is provided a more dynalnic view of this test series, as conlpared to 
the control cases in which there was survival of at least this develop after injections but this effect was highly variable. Studies 
interval. There was little difference in any of the groups for the of the peripheral lymphocytes in patients after transplantation 
first two months. After this, the creatinine clearances decreased in were even more difficult to interpret because of the complex 
control groups 2 and 3. These measures increased in control group immunosuppressive regimen being employed. For example it has 
I, but at only half the rate of an increase in the ALGtreated been shown (Starzl et al., 1965) that there is a direct correlation 
patients (Fig. 6). The late linear trend in creatinine clearance in the between the quantity ofsteroids used after transplantation, and the 
LYMPHOCYTE CWNT LYMROCYTE FRACTION degree of postoperative lymphopenia. As a consequence, com- 
parisons in the present study between the retrospective control 
cases and those treated with ALG were invalid in that the latter 
patients received far less ~rednisone. With this reservation in 
mind, it is noted in passing that the percentage of lymphocytes in 
the peripheral smear was approximately the same in &ch of the 
control groups as well as in the ALG-treated patients (Fig. 7). 
The total peripheral lymphocyte counts per day were slightly 
higher in the ALG group, being 1,7801mm.~ as compared to 
1,640, 1,510, and r ,q~o /mm.~  in the three control series. 
Rejection. Seven of the 19 patients with satisfactory operations 
have never experienced rejection. Secondary deteriorations of 
renal function occurred in the other 12. However, a rise in BUN 
after the initial diuresis to as high as 150 mg./~oo ml. occurred in 
only one case (Fig. 8), and to as high as IOO mg./~oo ml. in only one 
other. In the remaining patients, the nlaximurn secondary rise in 
BUN did not exceed 67 mg./~oo ml. These rejections were all 
easily reversed, as can be appreciated from the composite post- 
operative function curves of the first eight patients (Fig. 6). lymphocyte differential counts in the same series shown in Figs. 4 and 5 ,  
during the first 15 postoperative weeks. See text for discussion. Furthermore, delayed rejection has not been seen in any of the 
ALG-treated patients. 
ALG series was significantly different (P< o.005) from that in any Clinical toxicity. All patients had pain at the site of the intra- 
of the preceding controls. These fmdings indicate that deteriora- muscular injections. This was often severe and in a few cases 
tion of function did not occur during and after the attenuation and narcotics were required. The con~plaints were usually greatest 
final discontinuance of globulin therapy. Instead, the quality of with the first few injections. Later, most of the patients were not 
function improved progressively from the second month onwards. 
. prevented by the discomfort fro111 carrying on their regular 
EJect or1 white blood corrrits. The average white cell count per activities. Swelling and oedema were regularly observed, 
day for the first 105 postoperative days was higher in each suc- reaching a peak after three to six hours. It was at this time, rather 
ceeding series(Fig. 7). This probably resultedfrom theincreasingly thanimmediately after administration, that the pain was apparently 
cautious use of azathioprine described above. most intense. 
The influence of ALG on the lymphocyte differential fractions In addition, all patients developed fever at some time. Usually 
and the total lyrnpliocyte counts of patients being treated pre- this was low-grade fever and often it would not be observed after 
operatively solely with this agent was described previously every injection. In some cases, however, temperatures rose to 
(Iwasaki et a!., 1967). There was a tendency for lymphopenia to more than qo0c even when steroid therapy was in effect. Four of 
T. E. STARZL et al. HBTBROLOGOUS ANTILYMPHOCYTE GLOBULIN 19 a A tinued for a month or longer and then stopped either because of /' '\ I I I I similar further reactions (two cases) or because the interval of I I I I planned treatment had ended (one case). In the fourth patient, the 
azatGoprine was primarily ;esponsible for the bone marrow 
their earl~yostoperativ~ course to have low platelet counts, frail; 
. 
TIME IN MY3 
50,000 to 15o,ooo/mm.~, at the same timc as the peripheral 
leucocyte counts were normal or elcvatcd. In only onc case was . 
batch of ALG thenLbeing used was exirnined by Drs. A. van 
, I  U 
hypertensive. In three of these four patients, therapy was con- The more specific inforlhation 011 ALG toxicity which was 
sought with immunological measurements will be reported from and 4). In these patients, the precipitin titres fell after prednisone 
the first eight patients for whom the longest follow-ups are was begun in doses of 0.31 to I -37 mg./kg. per day. Two of 
available. Skin tests obtained before and after therapy showed an these three patients who had developed anaphylactic reactions 
increased reaction in five of the eight cases after several weeks or subsequently received ALG for four to eight weeks without 
months. The erythema, induration, or wheal formation were further difficulty; the third patient never had a reaction. The other 
five patients, in whom the precipitin increases were either later or 
of lesser magnitude, were treated in four instances with steroids 
beginning within the first two postoperative weeks. These 
findings suggested that prednisone therapy could reverse the 
precipitin response in situations where the foreign protein was 
continuously administered, or that alternatively the response 
could be attenuated if steroids were instituted at an earlier time. 
However, a second feature of the precipitin response deserves 
special emphasis since it did not follow the institution of steroid 
FIG. g. Rises in precipitin titres in the first eight consecutive patients treated 
with antilymphocyte globulin. The vertical arrows indicate the last dose 
of ALG given in each case; note that the titres had often begun to decline 
before this time. 
unchanged in the other three, with testing weekly or every other 
All patients developed increases in precipitin titres, 
beginning from two to nine weeks after the beginning of ALG 
therapy (Fig. 9). The timing and magnitude of the rises appeared There were five positive reactions, one to PPD, three to mumps 
to be influenced by several factors. The greatest and earliest and one to trichophyton. All skin tests became negative within 
precipitin activity was in three of the four patients who did not three or four days after ALG treatment began, thus demonstrating 
receive steroids until 29 to 43 days after transplantation (Cases I, 2, that the antilymphocyte globulin being used prevented the 
I 
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I - .  - - ~evertheles', the only serious infectious complication was pneumonitis in the patient who died after the technically unsatis- factorv transplantation. There was also one example of hcrnes 
FIG. I I .  Sanie renal homograft as was shown in Fig. 10. Sectio~l o f  
biopsy trcated with fluorescein-labelled goat antibody to Iluman 
inlmunoglobuli~l M. Thcre is a delicate granular and linear localizatio~l 
o f  IgM in the glorncrular capillary walls. (By courtesy o f  Drs. Andres, 
Hsu and Seegal.) x joo. 
zoster, and several minor upper respiratory ~ntectlons. 
Other nrorbidity. Two of the patients who are still alive required 
reoperation for urological complications. hl one, a urctero-pelvic 
stricture necessitated conversion at the ninth postoperative week 
of the ureteroneocystomy to a ureteropelvostomy. I11 the other, 
the tip of the honlograft ureter sloughed within the urcteroneo- 
cystostonly tunnel and a uretero-ureterostomy was required after 
I3  days. Both patients recovered promptly. 
Histopathological stt~dies. Subendothclial accuniulations of 
amorphous material were present in the glomerular capillary 
walls of six of the eight renal homografis biopsied 108 to 145 days 
I 
after homotra~uplantation (Table I), but only ill four of the kidneys 
could any thickening of the basenlent menlbranes be detected by 
light microscopy. The change was focal and in every glonlerulus 
normal loops were present. The density and compactness of the 
deposits varied Fig. 10); 111 one kidney it was as though the 
lamina densa ha d been split and a broad Land of loosely arranged 
material inserted between the two layers. Mesangial cell pro- 
cesses extended into a few of the thickened bascinelit men~bmncs. 
There were no subepithelial deposits. 
Immunofluorescence of the six affected kidncys dc~nonstrated 
I 
and fibrinogen. No localization 0 x 1 ~ ~  or hb& 
was detected. 
In all the kidneys with glomerular capillary basement membrane 
changes there was some increase in the number of mesangial cells 
and the amount of mesangial matrix; the epithelial, endothelial 
and mesannial cells possessed increased numbers of free ribosomes, 
cytes were present in the glomerilar c ap i l l a~ loops  of three of 
2 
interlobular arteries, in four of the kidneys these changes were \ 
minor and affected onlv a few vessels. In onlv two (LD I07 and I r ? .,. 
seven of the homografts and were frequent in four of these. Up -5. 1 5. 
.I I $ 1  I 
. - I .z plasmic reticulum. 7 .  A I w E d F . 2  ".a a 8 a I! 
Late cases 
In all four of these cases there was a fall in BUN with the institu- 1 
tion of ALG therapy and a subsequent reduction in prednisone n r . * ~ m  mouara Gcllrlrul r,or A,+ 
relativel; stabld in bite of the drastic withdrawal of standard I 
. - 
two of the three patients in which i n  infectious complication was I 
months after discontinuke of ALG. The fourth was a r p y e G  
old recipient of a cadaveric homograft whose renal function was c ; g s  5 ; :  z z - " E x  s O g c :  s " g g  x x sg 0  O a  0 extremely poor when globulin therapy was begun. Her course - % f i . 3 ~  
. . kl a, k-,., 
was not particularly different from that in the othc I 
I a~ ; 4 = .=.=a 1 ;ion survival of ten months.  he hornograf; weighed 9s a. if 5 -- $ 1  Y E  ~ g k ~  
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Microscopically many of the arteries were greatly narrowed by one, scarcely more impressive than in Woodruff's earlier negative 
fibrous intimal thickening This change was most severe in the experiments (1960). The subsequent investigations of woodruff 
interlobar and segmental arteries, several of which were com- and Anderson (1963, 1964) catalysed widespread interest in the 
pletely occluded, and it was sometimes accompanied by rupture therapeutic possibilities of such antisera by demonstrating a 
of the internal elastic lamina. The vascular lesions were associated striking protection of homografts in mice treated with ALS alone 
or in combination with thoracic duct drainage. Later, antisera of 
comparable or greater potency were developed by Gray, Monaco 
and Russeu (1964), Monaco, Wood and Russell (1965), Levey and 
Medawar (1966a, b) ,  Jeejeebhoy (1965), Nagaya and Sieker 
(1965)~ and Hoehn and Simmons (1966). In all these studies, the 
experimental model consisted of skin grafting in mice, rats, or 
guinea pigs which were treated, usually by intraperitoneal 
injection, with antisera raised in rabbits. The use of genetically 
controlled donor and recipient strains for transplantation per- 
mitted precise delineation of many of the features of the tested 
serawhich have direct clini~alapplicabilit~, as willbe discussedlater. 
Nevertheless, certain intermediary steps were required before 
heterologous antilyi~lphocyte products could be considered for 
slowly improved (Fig. 12). Her condition is now excellent, clinical trial. It was necessary to demonstrate a beneficial effect 33 months after discontinuation of ALG therapy. of ALS after whole-organ transplantation in outbred animals, to 
In another case, a slow but inexorablelate rejection ofacadaveric determine the therapeutic schedules which were the most effective 
homograft in a 13-year-old child could not be reversed with with the least toxicity, and to evolve practical teclmiques of 
high-dose prednisone therapy. This effort was complicated by administration which would be acceptable for use in man. This 
the development of acute pneumonitis. ALG therapy was kind of information has been sought in dogs. 
started, and continued for five weeks. Steroid therapy was First,heterologousALS raised in either the sheep(~itchel1 et al., 
reduced and then stopped, and ~lltirnately azathioprine and ALG 1966), rabbit (Abbott et ol., 1966; Lawson, Ellis and ~ o d ~ e s ,  1966) 
were also discontinued when the pneumonitis became worse. or horse (Abaza ct nl., 1966; Atai and ICelly, 1966; ~ul l t ley  et al., 
During the ensuing eight weeks the patient had continuing 1966; Pichlmayr, 1966; Starzl et al., 1966, 196~), and give11 intra- 
although slowly deteriorating renal function. The pulmonary venously, intraperitoneally or subcutaneously as the sole therapy. 
infection coinpletely resolved, and retransplantation was carried I has been shown to potentiate the survival of both canine renal and 
out 011 17 January, 1967. A second course of ALG therapy was liver homografts. The results in individual experiments in all 
started without untoward effects. these studies were inconsistent. There were some extraordinarily 
long-term survivors but most animals eventually rejected their 
DISCUSSION homografts. The same spectrum of response to therapy has been 
observed in the past with evaluatioli of azathioprine and other 
During the past .seven years, considerable information has iinn~unosuppressive agents, and is presumably the consequellce of 
accumulated concerning the immunosuppressive and other differences in the quality of chance hi~toconlpatibilit~ matching 
properties of heterologous antilymphocyte serum (ALS). Waks- in randomly paired mongrel dogs. 
man, Arbouys and Arnason (1961) were the first to show prolongs- The effectiveness of subcutaneous injections in these studies was 
tion of hoinograft survival but the effect was an extremely weak tt of the utmost importance since it was shown to carry far less risk 
I 
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of acute toxicity from anaphylaxis than the other routes of 
administration. These observations also led to the decision that 
intramuscular therapy would be the clinical procedure of choice, 
since, unlike the situation in the dog, injections are poorly tolerated 
in the fatty subcutaneous tissue of humans. Such therapy could 
not be considered in man until a potent product was refined which 
could be given in small amounts. This was accomplished, as 
detailed elsewhere (Iwasaki et ol., 19679, by raising and selectively 
absorbing high-titre antiserum, idenufying the imn~unoglobulin 
components which contained anti-white cell antibodies, and 
selectively removing these protein fractions. The resulting 
material was not only ofapractical volume, but contained reduced 
total quantities of horse protein. 
Concern about serum toxicity was not eliminated by tlie 
development ofan improved antilymphocyte globulin. Although 
acute anaphylaxis has never been seen in our laboratory after 
subcutaneous injections of ALG in dogs, there were at least two 
other well-known and immunologically distinct kinds ofreactions 
( ~ i x o n ,  196~)  which could, by virtue of renal injury, defeat the 
purpose of this treatment. 
The first of these was a Masugi-type nephritis in which a very 
rapid binding has been demonstrated of heterologous antikidney 
antibodies to glomerular antigen (Seegal et sl., 1962). With 
fluorescein-labelled antibody techniques the foreign protein 
could be seen for many months, mixed after the first week or so 
with secondary accumulations of host y-globulin and PIC com- 
plement. There was sound theoretical reason to fear this complica- 
tion since ALG-at least that produced in our laboratories-is 
I 
T. B. STARZL et al. HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN 
used in conjunction with azathioprine (Starzl et al., 1967) or other 
metabolites (Hoehn and Simmons, 1966), with prednisone (Levey 
and Medawar, 1966~11, and, under special circumstances, with total 
body irradiation (Levey and Medawar, 1966a). The detds of 
therapy were also influenced by the demonstrations in animals that 
homograft survival was improved if ALG was given for several 
days before as well as after transplantation (Huntley et al., 1966; 
Monaco et al., 1966; Starzl et al., 1967), and that lymphopenia was have required such adjustments. 
not essential for an immunosuppressive effect (Abaza et al., 1966; Possibly it will eventually be found that imnlune globuliii 
Huntley et al., 1966; Mitchell et al., 1966; Starzl et al., 1966,1967), t l~erap~is  feasible on a much more chronic basis. For the moment, 
for reasons best explained by the studies of Levey and Medawar it is encouraging to note that ALG could be used for several 
months without prohibitive direct toxicity, the only consistent 
1 
The results with the clinical use of ALG under these carefully side effects being pain at the injection site and fever. Anaphylactic 
defrned circumstances have been distinctly encouraging. There reactions which occurred in four patients were relatively minor 
have been fewer deaths and less disability after renal homo- and transient and in three of these cases a number of subsequent 
transplantation than at any previous time in our experience, injections were given. It i s  reasonable to believe that the con- 
observations which become increasingly significant with each comitant use of other iminunosuppressive drugs contributed to 
additional month of follow-up. It has been possible to maintain the safety of the globulin administration, a possibility which was 
excellent homograft f~~nction with smaller quantities of the supported by the facts that elevated precipitin titres declined 
standard immunosuppressive drugs. The drastic reduction in the promptly in three patients after late institution of prednisone 
requisite doses of prednisone was of particular importance, since therapy, and that such titres rose later and more sluggishly in other 
this agent has been thought to contribute more heavily than any patients in whom prednisone was started at an earlier time. 
other factor to both the delayed mortality and the morbidity after The most reassuring information, however, came from study of 
transplantation (Hill et al., 1967). The freedom ofthe ALG-treated the homograft biopsies. None showed anything suggestive of 
patients from infectious complications was striking. chronic serum sickness nephritis either by fluorescence microscopy 
The degree to which short-term treatment with heterologous or by electron microscopy. The only glomerular and vascular 
immune globulin will influence the long-term prognosis after lesions found were those that have been frequently encountered in 
renal homotransplantation remains speculative, but there is reason renal homografts treated in a conventional nlanner and that are 
to believe that any therapy which is of value during the early generally considered to be the result of the host's reaction to the 
post-transplant period may confer a lasting benefit. This is not foreign tissue (Porter et al., 1966,1967). Theinfiltration by lymph- 
because of a continuing iinnlunosuppressive effect. Rather, it oid and plasma cells was also no more dense than that often seen 
appears to be due to an alteration which leads to a state of relative in homografted kidneys at about this time after transplantation 
host-graft non-reactivity. This poorly understood change, (Hamburger et al., 1965). 
termed "adaptation" by Woodruff and Woodruff, who were S6 far, discussion has been confined to the newly operated cases 
the first to show its development (I~so),  is the cornerstone upon in which ALG was iven from before the time of transplantation. 
which many of the advances in clinical honlotransplantation are The effect of globu&n therapy upon the course of the other four 
based, since it implies that the maximum need for immuno- patients who had late-failing homografts is not easy to assess. 
suppression is soon after operation. More recently, it has often Renal excretion was not inlproved in any instance, but stabiliza- 
been possible to maintain patients for years on drug doses no tion of function was observed in two patients despite reductions 
greater or evcn less than those which at an earlier tinie were quite 1 in prednisone therapy of a magnitude which had previously been 
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impossible without precipitation of a rejection. In a third case, 
homograft function continued for two months in the absence of 
all therapy until retransplantation could be performed. It seems 
unlikely that ALG therapy can benefit many such patients unless 
it is given at an early time, before irreversible injury has occurred. 
Under these circumstances it may be possible to retain residual 
function with considerably less stringent prednisone therapy. 
Benefit of this kind would not be surprising since it has been 
shown that ALS can erase the immunological memory of pre- 
sensitized animals (Levey and Medawar, 1966a; Monaco et al., 
1966), and because the abolition of pre-existing delayed hyper- 
sensitivity skin reactions in patients has been demonstrated within 
a few days of the institution of ALG therapy. 
SUMMARY 
An antihuman-lymphocyte globulin (ALG) was prepared from REFERENCES 
the serum of immunized horses for intramuscular administration ABAZA, H. M., NOLAN, B., WATT, J. G., and WOODRUFF, M. F. A. (1966). 
in man. From June until December, 1966, it was used as an Transplantation, 4 ,  618-632. 
adjuvant immunosuppressive agent for the treatment of 20 ABBOIT, W. M., OTHERSON, H. B., MONACO, A. P., SIMMONS, R. L., 
patients before and after renal homotransplantation in accord- WOOD, M. L., and RUSSELL, P. S. (1966). Surg. Forctrn, 17, 228-230. ATAI, M., and KELLY, W. D. (1966). Surg. Fonttn, 17, 249-251. 
ance with guide-lines derived from previous animal experiments. DAVIDSOHN, I. (1929). 1. Imnauit., 16,259-273. 
The ALG was added to therapy with azathioprine and prednisone, DIXON, F.J. (1965). Fedn Roc.  Fedtr Anr. Socs exp. Biol., 24,98-99. 
and its use was restricted to the critical first four postoperative DIXON, F. J., FELDMAN, J. D., and VAZQUEZ, J. J. (1g61).]. exp. Med., 113, 
months. During the preoperative period when it was used alone, J 899-920. 
the ALG invariably abolished pre-existing delayed hypersensiti- FELDMAN, J. D. (1963). In Imnrunopathology: Tliird Itlterizational Syrrryosiunr, p. 263, ed. Grabar, P., and Miescher, P. A. Basle: Schwabe and Co. 
vity skin tests ofvariom kinds, an action which was not dependent GRAY, J. G., MONACO, A. P., and RUSSELL, P. S. (1964) Surg. Forunl, IS, 
upon lymphopenia. 142-144. 
Nineteen of the patients are alive and well; the only death GRAY, J. G., MONACO, A. P., WOOD, M. L., and RUSSELL, P. S. (1966). 1. 
resulted after a technical accident in a patient whose homograft Immurr., 96, 217-228. HAMBURGER, J.. CROSNIER, J., DORMONT, J., REVEILLAUD, R.-J., HORS, 
also developed the same acute glomerulonephritis as had originally J.-H., and ALSINA, J. (1965). Presse ritid., 73, 2873-2879. 
afflicted his own kidneys. Severe rejection was not observed. HJLL, R. B., Jr., DAHRLING, B. E., STARZL, T. E., and RIFKIND, . (1967). 
The doses of both azathioprine and prednisone used were less Am.  1. Med., in press. 
than in any previous series of transplantations at our institutions. HOEEIN, R., and SIMMONS, R. L. (1966). Surg. Forctrrr, 17,251-253. HUNTLEY, R. T.,TAYLoR,P. D , Iwasmr,Y. MARCHIORO T. L., JEEJEEBHOY, There has been only one serious infectious complication in the H., PORTER, K. A., and STARZL, T. E. (1966). Surg. Forrrrri, 17,230-233. 
entire series. Renal function in all ten of the patients who received IWASAKI, Y., PORTER, K. A., AMEND, J. R., MARCHIORO, T. L., ZWHLKE, v.  
transplantation more than three months ago is normal. In four and STARZL, T. E. (1967). Surgery Gynec. Obstet., 124, 1-24. 
more patients ALQ therapy was used for patients with late-failing JBBJEEBHOY, . F. (1965). Inmlutiology, 9,417-425. LACHMANN, P. J., MULLBR-EBERHARD, H. J.,KUNKEL, H. G.,and PARONETTO, homografts; the results in these cases were equivocal. F. (1962). J. exp. Med., 115.63-82. 
The question of foreign protein toxicity was examined. De- I LAURELL, C. B. (1966). Analyt. Biochern., 15, 45-52. 
RBPERBNCES DISCUSSION 
DISCUSSION 
Cell:  As the cytotoxicity of serum of this type depends on comple- 
56,1130-1137. ment, the absence of the Fc fragment would  res sum ably lead to its being 
LEVEY, R. H., and MBDAWAR, P. B. (1966b). Ann. N.Y. Acad. Sci., 129, both less immunogenic and less cytotoxic. Has anyone tried chopping 
that fragment off with papain? MCCLUSKBY, R. T. (1965). In The Itflattimatory Process, pp. 649-683, ed. 
Zweifach, B. W., Grant, L., and McCluskey, R. T. New York: Russell: Dr. Henry Winn in our laboratory has removed the Fc frag- 
Academic Press. ment of ALS by papain digestion, but so far the material is 0111~ in a bottle 
Ma=, D., HARTLEY, T. E, and CLAMAN, H. N. (1967). J. Lab. clin. and not in an animal. 
Med., 69, 151-159. Cell:  Is the pain patients feel after injection due to a local Arthus 
MITCHELL, R. M., SHEIL, A. G. R., SLAFSKY, S. F., and MURRAY, J.E. (1966). 
Transplantation, 4, 323-328. 
MONACO, A. P., WOOD, M. L., GRAY, J. G., and RUSSELL, P. S. (1966). J. 
Immun., 96,229238. 
MONACO, A. P., Wood, M. L., and RUSSELL, P. S. (1965). Science, 149, 
NAGAYA, H . ,  and SIEKER, H. 0. (1965). Science, 150, 1181-1183. 
PORTER, K. A., RENDALL, J. M., STOLINSKI, C., TBRASAKI, P. I., MARCHIORO, 
T. L., and STARZL, T. E. (1966). Ann. N.Y. Acad. Sci., 129, 615-636. 
SEEGAL, B. C., HSU, K. C., ROTHBNBURG, M. S., and CHAPEAU, M. L. 
(1962). Anr. J. Path., 41, 183-197. 
STARZL, T. E., MARCHIORO, T. L., FARIS, T. D., MCCARDLE, R. J., and 
IWASAKI, Y. (1966). Am. J. Surg., 112, 391-4m. 
STARZL, T. E., MARCHIORO, T. L., PORTBR, K. A., IWASAKI, Y., and CERILLI, evokedlittle precipitinresponse, it seems likely that the pure IgG prepara- 
G. J. (1967). Surgery Gynec. Obstet., 124, 301-318. tions will be safer than the product now being used. 
STARZL, T. E., MARCHIORO, T. L., TERASAKI, P. I., PORTER, K. A., FARIS, I Woodru# W e  have only treated one patient with horse antihuman 
T.D., HERRMANN, T. J., VREDEVOE. D  L., HUTT, M. P., OGDEN, D. A., globulin, and this was a girl in whom irreversible changes had already 
and WADDELL, W. R. (1965). Ann. Surg., 162,749789. taken place.  he graft had been in place for a year so we were not really 
STARZL, T. E.. MARCHIORO, T. L., and WADDELL, W. R. (1963). Surgery expecting any miracles but we wanted to establish the safety of the pro- 
Gyt~ec.  Obstet., 117, 385-395. cedure. This girl first had a course of intramuscular injections for about 
STRAUSS, A. J. L., KEMP, P. G., Jr., VANNIOR, W. E., and GOODMAN, H. C. 
(1964). 1. Itiinruri., 93, 24-34. eight days and she had local pain and considerable red swelli~~gs at the 
TERASAKI, P. I., VREDEVOE, D. L., PORTBR, K. A., MICKEY, M. R., MARCHI- site of the injections, despite the fact that she was on fairly lieav doses of 
ORO, T. L., FARIS, T. D., HERRMANN, T. J., and STARZL. T. E. (1966). steroids at the time. Two months later we gave her a secondlfive-day 
Transplantation, 4, 688-699. courseintravenously because ofthese complications, but to this she showed 
WAKSMAN, B. H., ARBOWS, S., and ARNASON, B. G. (1961). J. rxp. Med., no reaction and hadno painwhatever. I don't think this treatment achieved 
114, 997-1022. any dramaticchangesin the transplant and Iamnot particularly advocating 
WOODRUFF, M. F. A. (1960). In The Transplatltation of Tissues and Organs. the intravenous route, but it was interesting that it was so well tolerated. 
pp. 100-101, 150- IS^. Springfield, lllinois: Charles C. Thomas Co. Wewerestruckby thefact(Abaza etal., 1966, bc .  cit.) that aserum-sickness- 
WOODRUFF, M. F. A., and ANDERSON, . F. (1963). Nature, Lond., ZOO, 702. like phenomenon occurred in the dog after crude horse serum (whether 
WOODRUFP, M. F. A., and ANDERSON.  P. (1964). Anti. N.Y. Acad. Sci., ALS or normal serum) was administered, but whereas this recurred in a 
120, 119-128. 
WOODRUFP, M. F. A., and WOODRUFP, H. E. (1950). Phil. Trans. R. Soc., much more severe form at eight days or so in control animals in which 
234, 559-582. J normal horse serum was used, there was no later reactionin animals which 
I 
I 
DISCUSSION DISCUSSION 
that is not to have irrelevant antigens present in the first place. and there- 
fore to raise antisera not by injecting whole cells but by injecting fractions 
of cells. There seems no reason why one should go to all the trouble of 
inducing the formation of high titres of antibodies which one doesn't 
want. We know that certainlymphocyte cell fractions will produce ALS- 
type antibodies extremely well, and indeed better than whole cells, 
and I should have thought this was the kind of thing that ought to be 
done now in clinical practice. Those who are injecting ALS into 
human beings should tell us what material they are using to raise their 
~ t a r z l :  We immunized with whole cells. At first, we used lymphocytes 
from thymuses and lymph nodes. It was unusual to retrieve as many as a 
billion cells from a cadaveric donor. We eventually began to use spleens 
in order to get larger doses of antigen. A cadaveric human spleen ordina- 
Janles: Our preparations contain only IgG and IgG(T) and immune rily provides 40 to zoo x 109 cells. Before making this change, we could 
elimination occurred, suggesting that antibodies are being produced not obtain leucoagglutinating titres much higher than I :64 in our horses. 
against these proteins. However the use of a stronger antiserum might Afterwards, the titres rose within a few weeks to as high as I : 16,000 or 
completely suppress humoral antibody formation, thus preventing even greater. 
immune elimination. Monaco: We used lymphocytes from lyrnpll nodes as the imm~inizing 
Balner: Serum from monkeys treated with purified IgG did not contain material. When we raised our antihuman lymphocyte serum in horses 
demonstrable precipitins, whereas serum from monkeys treated with we found that all horses had very large amounts ofcirculating IgG, so that 
whole serum usually contained precipitins against rabbit proteins but not we were adding our specific antibody to a large pool ofIgG and recovering 
this in the purified preparations. Our material from tlie horse had 45 mg. 
proteinlml. If we used young rabbits with very low levels of IgG to 
start with and then immunized them, we could get a material with a 
comparable lymphoagglutinin with 10 mg. proteinlml., so that we 
I subsequently administered a much smaller amount of protein. We still 
I get irrelevant antibodies, but we have been able to reduce the amount of 
I 
1 Jatnes: The question of the species in which the antiserum is raised is a 
I very important one. First of all we have to consider the ability of the 
immunized species to produce antibody against the injected lymphocytes. 
Secondly there is the question of the immunogenicity of the antilympho- 
cytic antibody preparations in the animal receiving this form of treatment. 
In our experiments the rabbit antirat material was more effective than the 
horse antirat lymphocyte IgG preparations. Furtl~crmore the rabbit IgG 
I is less immunogenic in the rat than the horse preparations and so is less 
I readily eliminated by immune mechanisms. The rabbit antibody may 
i therefore remain in the body for a greater length of time and thus 
exert a prolonged effect. 
Russell: A priori, this makes sense, but I don't think we know yet 
whether immunogenicity ofthe ALS preparation is a good or a bad thing. 
It may turn out that irnm~no~enicity of tlie heterologous protein is a 
very important aspect of its mechanism of action. This question of 
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25 or 30 per cent in a few days. 
Taub: With a highly haemolytic serum, correlation of degree of 
anaemia with agglutinin titre becomes even less meaningful. Also, the 
dogs were not getting steroids. With your absorbcd sera, what was the 
transfusion requirement in these patients? 
Starzl: In patients we have never seen anaemia resulting from ALG. 
Medawar: They would be antibodies to every ingredient ?f, shall we We did have a bad batch ofALG which hadn't been completely absorbed. 
say, a human lymphocyte that was not also possessed by a horse. We used it for a few days until we found that it had a haenlagglutinin 
Woodrrtfl: Are there other effective antigenic determinants in the titre of about I: 1,000 as well as a haemolysin titre of I :256. We stopped 
human lymphocytes that are going to immunize the horse, apart from using it. There were no apparent harmful effects. 
tlie ones presented in your membrane preparations? That is really my Woodr@ But there is no doubt that it makes both rats and dogs 
extremely anaemic. It would be a mistake to gloss over this. 
Taub: We can make our mice anaemic even with the red-cell absorbed 
serum. 
Calrze: I am sure that Professor Woodruff was not suggesting that 
antilymphocytic serum should not be used clinically. We have used 
Imuran (Burroughs Wellcome) and steroids for several years now, and 
we have no idea how they act, but we know that they do act. Professor 
Woodruj;  An inlportant gneral point is really at issue here. The 
human work has to tag along behind basic biological observations and this 
sort of question I have put is the kind of thing that would be answered in 
animal systems. Clinicians slio~lld not try to be too pure until biologists 
have shown them the way. 
Medaluar: There is verylittle danger of that ! Animal experiments have 
I already shown, for examplc, that crude so-called membrane fractions from lymphocytes are extremely good ALS ~roducers (Levey, R. H., and 
I 
! Medawar, P. B. [1966]. Proc. rmtrr. Acad. Sci. U.S.A., 56, 1130). 
\ Batc/zelor: Professor Starzl, what happened to tlle haemagglutinin 
tltrcs and your horse sera whe11 you switched froni using thymus and 
lyn~pli node cells as your antigen to using spleen cells? It is quite a severe 
practical problem getting rid ofthe haema glutinins, which I would have 
thought was a desirable thing to do, am! I would have expected very 
high haemagglutinin titres to appear when you switched to using spleen. 
Stnrzl: The haemagglutinin titreswere sometimes as high as I : IOO,OOO. 
These can be absorbed with htlman red cells without reducing the anti- 
white cell titre. It is a practical problem only for the technician who has 
to do it. It takes about three days. 
Tarr6: The liae~na~glutinin titres will not specifically indicate how 
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